Merger SPKBU

Eleusis and Silver Spike Acquisition Corp. II Mutually Agree to Terminate Business Combination Agreement


Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II (NASDAQ: SPKB), today announced that they have mutually agreed to terminate their previously announced agreement and plan of merger, effective immediately, as a result of current unfavorable market conditions.

Silver Spike II intends to continue in its efforts to identify a prospective target business for an initial business combination.

Read more